Articles on Antiretroviral therapy

Displaying all articles

Only three per cent of HIV organizations in British Columbia offer basic dental care to those who need it. (Shutterstock)

People living with HIV struggle to access much-needed dental care

Research shows that many people living with HIV struggle with tooth decay, bleeding gums and tooth sensitivity -- due to the costs of dental care and discrimination by dental professionals.
In the Democratic Republic of Congo, HIV is still highly stigmatised. MSF/Tommy Trenchard

HIV is still taboo in the DRC: chronicles from Kinshasa

HIV remains a synonym for death in Kinshasa and many leave testing and treatment until it's too late. It's not common knowledge that an infected person can live a normal and healthy life.
A client receives HIV/AIDS counseling at a women and children’s hospital in Nigeria. These facilities are not always available in rural areas. Flickr/ Karen Kasmauski/MCSP

Nigeria wants to decentralise HIV treatment. But it’s proving difficult

Effectively decentralising HIV and AIDS treatment services helps to improve universal health care. But in Nigeria this approach comes with many challenges.
This human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. T cells play a critical role in the body’s immune response. Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health

A cure for HIV: what science knows, and what it doesn’t

HIV research continues to search for a cure. The focus is on developing therapies to cure HIV infection or allow people with HIV to safely stop antiretroviral therapy and keep the virus under control.
South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all. International AIDS Society/Rogan Ward

It will take more than $36 billion every year to end AIDS

Current epidemiological and financial trends suggest there's a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.

Top contributors

More